MicroRNA expression profiling in male and female familial breast cancer.

Abstract:

BACKGROUND:Gender-associated epigenetic alterations are poorly investigated in male and female familial breast cancer (fBC). MicroRNAs may contribute to the different biology in men and women particularly related to RASSF1A pathways. METHODS:Microarray technology was used to evaluate miRNA profile in 24 male and 43 female fBC. Key results were validated using RT-qPCR in an external samples set. In vitro studies were carried out to verify microRNA-target gene interaction. RESULTS:Pathway enrichment analysis with the 287 differentially expressed microRNAs revealed several signalling pathways differently regulated in male and female cases. Because we previously hypothesised a peculiar involvement of RASSF1A in male fBC pathogenesis, we focussed on the MAPK and the Hippo signalling pathways that are regulated by RASSF1A. Male miR-152 and miR-497 upregulation and RASSF1A and NORE1A interacting gene downregulation were observed, confirming a possible indirect interaction between miRNAs and the two genes. CONCLUSIONS:For the first time, a different microRNA expression pattern in male and female fBC has been shown. Moreover, the importance of RASSF1A pathway in male fBC carcinogenesis has been confirmed, highlighting a possible role for miR-152 and miR-497 in controlling MAPK and Hippo signalling pathways, regulated by RASSF1A.

journal_name

Br J Cancer

authors

Pinto R,De Summa S,Danza K,Popescu O,Paradiso A,Micale L,Merla G,Palumbo O,Carella M,Tommasi S

doi

10.1038/bjc.2014.535

subject

Has Abstract

pub_date

2014-12-09 00:00:00

pages

2361-8

issue

12

eissn

0007-0920

issn

1532-1827

pii

bjc2014535

journal_volume

111

pub_type

杂志文章
  • A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.

    abstract:BACKGROUND:Lymphovascular invasion (LVI) is associated with the development of metastasis in invasive breast cancer (BC). However, the complex molecular mechanisms of LVI, which overlap with other oncogenic pathways, remain unclear. This study, using available large transcriptomic datasets, aims to identify genes assoc...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-019-0486-6

    authors: Kurozumi S,Joseph C,Sonbul S,Alsaeed S,Kariri Y,Aljohani A,Raafat S,Alsaleem M,Ogden A,Johnston SJ,Aleskandarany MA,Fujii T,Shirabe K,Caldas C,Ashankyty I,Dalton L,Ellis IO,Desmedt C,Green AR,Mongan NP,Rakha EA

    更新日期:2019-06-01 00:00:00

  • Tamoxifen induction of angiogenic factor expression in endometrium.

    abstract::Tamoxifen is the current therapy of choice for patients with oestrogen receptor positive breast cancer, and it is currently under evaluation as a prophylactic for women at high risk of developing the disease. However, tamoxifen is also known to induce proliferative changes in the endometrium increasing the risk of dev...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600157

    authors: Hague S,Manek S,Oehler MK,MacKenzie IZ,Bicknell R,Rees MC

    更新日期:2002-03-04 00:00:00

  • Oncofoetal antigens in cancer of the cervix and ovary.

    abstract::The incidence of oncofoetal antigens has been reported to be increased in patients with gynaecological cancers. In this study the incidence of CEA, AFP, and hCG (beta subunit) were studied in patients with adenocarcinoma of the ovary, adenocarcinoma of the cervix, and squamous-cell carcinoma of the cervix. Using a low...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1981.198

    authors: Cauchi MN,Koh SH,Lim D,Hay DL

    更新日期:1981-09-01 00:00:00

  • Targeting lymphangiogenesis to prevent tumour metastasis.

    abstract::Recent studies involving animal models of cancer and clinicopathological analyses of human tumours suggest that the growth of lymphatic vessels (lymphangiogenesis) in or nearby tumours is associated with the metastatic spread of cancer. The best validated molecular signalling system for tumour lymphangiogenesis involv...

    journal_title:British journal of cancer

    pub_type: 杂志文章,评审

    doi:10.1038/sj.bjc.6603120

    authors: Achen MG,Mann GB,Stacker SA

    更新日期:2006-05-22 00:00:00

  • A phase I study of intravenous bryostatin 1 in patients with advanced cancer.

    abstract::Bryostatin 1 is a novel antitumour agent derived from Bugula neritina of the marine phylum Ectoprocta. Nineteen patients with advanced solid tumours were entered into a phase I study to evaluate the toxicity and biological effects of bryostatin 1. Bryostatin 1 was given as a one hour intravenous infusion at the beginn...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/bjc.1993.352

    authors: Prendiville J,Crowther D,Thatcher N,Woll PJ,Fox BW,McGown A,Testa N,Stern P,McDermott R,Potter M

    更新日期:1993-08-01 00:00:00

  • Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.

    abstract::Eighteen consecutive patients with measurable locally advanced or metastatic pancreatic adenocarcinoma were treated with goserelin (Zoladex) 3.6 mg subcutaneously every 4 weeks. Hydrocortisone 20 milligrams twice daily was commenced with the second injection of goserelin. Objective tumour response was monitored by com...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/bjc.1993.69

    authors: Philip PA,Carmichael J,Tonkin K,Buamah PK,Britton J,Dowsett M,Harris AL

    更新日期:1993-02-01 00:00:00

  • Concurrent chemoradiotherapy for squamous cell carcinoma of the anus using a shrinking field radiotherapy technique without a boost.

    abstract::Chemoradiotherapy (CRT) is now widely accepted as the primary treatment modality for squamous cell cancer of the anus. While randomised trials have clearly shown CRT to be more effective than radiotherapy alone, there remains uncertainty over the optimal integration of chemotherapy and radiation. We describe a series ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6600913

    authors: Melcher AA,Sebag-Montefiore D

    更新日期:2003-05-06 00:00:00

  • Measurement of Gross cell-surface antigen and p30 level in murine retrovirus-infected cell lines.

    abstract::The level of Gross cell-surface antigen (GCSAa) expression at the surface of murine retrovirus-infected fibroblasts was determined by quantitative absorption of the anti-GCSAa activity of a serum produced in syngeneic W/Fu rats immunized against (C58NT)D lymphoma, and tested in a cytotoxicity assay against E male G2 l...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1981.97

    authors: Gerlier D,Gisselbrecht S,Guillemain B,Doré JF

    更新日期:1981-05-01 00:00:00

  • c-myc oncogene product expression and prognosis in operable breast cancer.

    abstract::The 62 kDa protein product of the c-myc oncogene (p62 c-myc) is thought to be involved in the control of normal cellular proliferation and differentiation. We have measured oncoprotein levels using a flow cytometric assay in 141 operable breast cancers and have correlated levels with prognostic variables, patient surv...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1989.337

    authors: Locker AP,Dowle CS,Ellis IO,Elston CW,Blamey RW,Sikora K,Evan G,Robins RA

    更新日期:1989-11-01 00:00:00

  • First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence.

    abstract::As of June 1998, four randomized trials have been completed comparing the combination of paclitaxel and cisplatin with a cisplatin-based control arm. The results of three of these trials are available; one has been published as a full paper, the other two in abstract form only. Two of the reported trials (GOG-111 and ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1998.709

    authors: Sandercock J,Parmar MK,Torri V

    更新日期:1998-12-01 00:00:00

  • Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality.

    abstract:BACKGROUND:The aim was to evaluate whether this gastric cancer-screening programme was effective in reducing oesophageal cancer mortality. METHODS:A population-based retrospective cohort study was conducted using the Korean National Cancer Screening Programme (NCSP) database. The study cohort comprised 16,969 oesophag...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/s41416-020-0883-x

    authors: Kim JH,Han KD,Lee JK,Kim HS,Cha JM,Park S,Kim JS,Kim WH,Big Data Research Group (BDRG) of the Korean Society of Gastroenterology (KSG).

    更新日期:2020-08-01 00:00:00

  • Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy.

    abstract:BACKGROUND:There have been controversies in prognostic impact of mucinous histology on colorectal cancer, and its implication in patients treated with adjuvant 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) is unclear. METHODS:Stage II and III colorectal cancer patients who underwent curative resection followed ...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.232

    authors: Lee DW,Han SW,Lee HJ,Rhee YY,Bae JM,Cho NY,Lee KH,Kim TY,Oh DY,Im SA,Bang YJ,Jeong SY,Park KJ,Park JG,Kang GH,Kim TY

    更新日期:2013-05-28 00:00:00

  • Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma.

    abstract::Clonal subpopulations of different ploidy values and metastatic capacities, isolated from the RIF-1 mouse sarcoma, have been tested for in vitro X-radiation sensitivity, for in vitro sensitivity to adriamycin and for in vitro and in vivo sensitivity to melphalan and CCNU. Following X-radiation, no consistent differenc...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1983.139

    authors: Reeve JG,Wright KA,Twentyman PR

    更新日期:1983-06-01 00:00:00

  • Phase I trial and pharmacokinetics of the tubulin inhibitor 1069C85--a synthetic agent binding at the colchicine site designed to overcome multidrug resistance.

    abstract::The orally administered tubulin-binding agent 1069C85 was developed with the hope of overcoming the multidrug resistance associated with existing anti-tubulin agents, such as the vinca alkaloids. A phase I study was performed using a single oral dose every 3 weeks, administered as a suspension reconstituted in 0.1% Tw...

    journal_title:British journal of cancer

    pub_type: 临床试验,杂志文章

    doi:10.1038/bjc.1997.107

    authors: Judson I,Briasoulis E,Raynaud F,Hanwell J,Berry C,Lacey H

    更新日期:1997-01-01 00:00:00

  • Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

    abstract::Supplementary Table 1 and the Supplementary Figure legends were not included when this manuscript was first published. The files are now available here. ...

    journal_title:British journal of cancer

    pub_type: 已发布勘误

    doi:10.1038/s41416-018-0130-x

    authors: Lièvre A,Ouine B,Canet J,Cartier A,Amar Y,Cacheux W,Mariani O,Guimbaud R,Selves J,Lecomte T,Guyetant S,Bieche I,Berger F,de Koning L

    更新日期:2018-08-01 00:00:00

  • One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis.

    abstract:BACKGROUND:To estimate the accuracy of one-step nucleic acid amplification (OSNA) assay as an intra-operative sentinel lymph node biopsy (SLNB) for sentinel lymph node (SLN) metastasis in breast cancer. METHODS:PubMed, Cochrane Library and Web of Science databases were searched by two independent reviewers to retrieve...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析

    doi:10.1038/bjc.2017.262

    authors: Shi F,Zhang Q,Liang Z,Zhang M,Liu X

    更新日期:2017-10-10 00:00:00

  • Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.

    abstract:BACKGROUND:Topoisomerase I (Topo I) poisons (e.g., camptothecin (CPT)), used to treat cancer, cause DNA breaks that are most cytotoxic during S phase. PARP-1 promotes DNA repair and PARP inhibitors (PARPi) sensitise cells to Topo I poisons. We aimed to determine whether chemosensitisation is also S phase specific using...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2014.378

    authors: Znojek P,Willmore E,Curtin NJ

    更新日期:2014-09-23 00:00:00

  • Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974-97.

    abstract::In Vaud, Switzerland, the incidence of carcinoids based on 218 malignant and 215 benign cases rose from 19.6/10(6)in 1974-85 to 28. 2/10(6)in 1986-97, more so among males and malignant neoplasms. Lung was the commonest site for malignant and large intestine for benign carcinoids. Sixty-eight (16%) carcinoids had anoth...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1054/bjoc.2000.1394

    authors: Levi F,Te VC,Randimbison L,Rindi G,La Vecchia C

    更新日期:2000-10-01 00:00:00

  • A nested case-control study of adjuvant hormonal therapy persistence and compliance, and early breast cancer recurrence in women with stage I-III breast cancer.

    abstract:BACKGROUND:Non-persistence and non-compliance are common in women prescribed hormonal therapy for breast cancer, but little is known about their influence on recurrence. METHODS:A nested case-control study of associations between hormonal therapy non-persistence and non-compliance and the risk of early recurrence in w...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.518

    authors: Barron TI,Cahir C,Sharp L,Bennett K

    更新日期:2013-09-17 00:00:00

  • Artificial sweeteners and bladder cancer in Manchester, U.K., and Nagoya, Japan.

    abstract::We have evaluated the relation between cancer of the lower urinary tract ("bladder cancer") and the use of artificial sweeteners, by means of case-control studies in Manchester, U.K., and Nagoya, Japan, areas where extensive use occurred 30-40 years ago. In each area, a broadly based series of cases (555 in Manchester...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1982.59

    authors: Morrison AS,Verhoek WG,Leck I,Aoki K,Ohno Y,Obata K

    更新日期:1982-03-01 00:00:00

  • Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

    abstract::There is increasing evidence that essential fatty acids (EFA) may have a role to play in the aetiology of some types of cancer although their precise mode of action is unknown. Differences in the metabolism of EFA between patients with benign or malignant prostatic disease may help to elucidate their role in the latte...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1991.481

    authors: Chaudry A,McClinton S,Moffat LE,Wahle KW

    更新日期:1991-12-01 00:00:00

  • Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion.

    abstract:BACKGROUND:Previous studies have demonstrated that senescent cancer-associated fibroblasts (CAFs) derived from genetically unstable oral squamous cell carcinomas (GU-OSCC), unlike non-senescent CAFs from genetically stable carcinomas (GS-OSCC), promoted keratinocyte invasion in vitro in a paracrine manner. The mechanis...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2014.438

    authors: Hassona Y,Cirillo N,Heesom K,Parkinson EK,Prime SS

    更新日期:2014-09-09 00:00:00

  • Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer.

    abstract:BACKGROUND:Paired related homoeobox 1 (PRRX1) has been identified as a new epithelial-mesenchymal transition (EMT) inducer in breast cancer. However, the function of PRRX1 in colorectal cancer (CRC) has not been elucidated. METHODS:We utilised ectopic PRRX1-expressing cell lines to analyse the function of PRRX1 in CRC...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.2013.339

    authors: Takahashi Y,Sawada G,Kurashige J,Uchi R,Matsumura T,Ueo H,Takano Y,Akiyoshi S,Eguchi H,Sudo T,Sugimachi K,Doki Y,Mori M,Mimori K

    更新日期:2013-07-23 00:00:00

  • The quantitative response of human tumours to radiation and misonidazole.

    abstract::Eleven patients with measurable subcutaneous or pulmonary metastases were selected for a study of the effectiveness of the radiosensitizer misonidazole (MIS). Evaluable data were obtained in 6 patients and radiosensitization demonstrated in 5. Patients were irradiated either before or after MIS, and each patient acted...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1979.281

    authors: Ash DV,Peckham MJ,Steel GG

    更新日期:1979-12-01 00:00:00

  • Possible associations between ELF electromagnetic fields, DNA damage response processes and childhood leukaemia.

    abstract::Epidemiology has shown an association between exposure to extremely low frequency (ELF) electromagnetic fields (EMF) and childhood leukaemia. The causal nature and biological basis of this association are however questionable. Studies with aneuploid cell lines raised the hypothesis that ELF EMF may act as a coleukaemo...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6601010

    authors: Hone P,Edwards A,Halls J,Cox R,Lloyd D

    更新日期:2003-06-16 00:00:00

  • Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis.

    abstract::The role of the anti-apoptotic protein Bcl-2 in lung cancer remains controversial. In order to clarify its impact on survival in small and non-small cell lung cancer (NSCLC), we performed a systematic review of the literature. Trials were selected for further analysis if they provided an independent assessment of Bcl-...

    journal_title:British journal of cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1038/sj.bjc.6601095

    authors: Martin B,Paesmans M,Berghmans T,Branle F,Ghisdal L,Mascaux C,Meert AP,Steels E,Vallot F,Verdebout JM,Lafitte JJ,Sculier JP

    更新日期:2003-07-07 00:00:00

  • A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.

    abstract::To determine the maximum-tolerated dose (MTD), dose-limiting toxicities and pharmacokinetic of semisynthetic homoharringtonine (ssHHT), given as a twice daily subcutaneous (s.c.) injections for 9 days, in patients with advanced acute leukaemia, 18 patients with advanced acute myeloid leukaemia were included in this se...

    journal_title:British journal of cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1038/sj.bjc.6603265

    authors: Lévy V,Zohar S,Bardin C,Vekhoff A,Chaoui D,Rio B,Legrand O,Sentenac S,Rousselot P,Raffoux E,Chast F,Chevret S,Marie JP

    更新日期:2006-08-07 00:00:00

  • Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.

    abstract::The haemodynamics of the uterine arteries and myometrium were assessed using Doppler ultrasound in forty consecutive patients requiring treatment for invasive mole and choriocarcinoma. The investigations were performed prior to the commencement of chemotherapy and the subjects followed prospectively. The Doppler wavef...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1992.379

    authors: Long MG,Boultbee JE,Langley R,Newlands ES,Begent RH,Bagshawe KD

    更新日期:1992-11-01 00:00:00

  • Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

    abstract::In adults, the haemolytic-uraemic syndrome (HUS) is associated with probable causative factors in the minority of all cases. Cytotoxic drugs are one of these potential causative agents. Although metastatic cancer by itself is a recognized risk-factor for the development of HUS, therapy with mitomycin-C, with cis-plati...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/sj.bjc.6690242

    authors: Serke S,Riess H,Oettle H,Huhn D

    更新日期:1999-03-01 00:00:00

  • Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone.

    abstract::The mechanism of down-regulation of c-myc RNA associated with androgen-induced suppression of the transformed phenotype in the human prostate carcinoma cell line LNCaP was investigated. The synthetic androgen mibolerone (7 alpha-17 alpha-Dimethyl-19-nortestosterone) reversibly inhibits the proliferation of LNCaP cells...

    journal_title:British journal of cancer

    pub_type: 杂志文章

    doi:10.1038/bjc.1992.76

    authors: Wolf DA,Kohlhuber F,Schulz P,Fittler F,Eick D

    更新日期:1992-03-01 00:00:00